Unscripted - The AMCP Podcast

AMCP
  • 5.0 (1)
  • HEALTH & FITNESS
  • UPDATED MONTHLY

Welcome to Unscripted, the AMCP Podcast — a look inside managed care pharmacy. Listen in as experts explore the challenges, innovations, and opportunities shaping health care for millions of patients.

  1. 12H AGO · VIDEO

    Ep. 55 - CLL Evolution: Fixed-Duration Therapy, NCCN Guidelines, and Managed Care

    In this episode of Unscripted, the AMCP podcast, host Laura Bobolts, PharmD, BCOP, talks with Kirollos Hanna, PharmD, Director of Pharmacy at Minnesota Oncology, about the rapidly shifting treatment landscape for chronic lymphocytic leukemia (CLL). The discussion covers the transition toward oral fixed-duration frontline regimens, the latest 2026 NCCN guidelines, and the emerging role of MRD testing. They also explore the clinical and economic implications of these therapies, including how the Inflation Reduction Act (IRA) is reshaping Medicare formulary strategies and patient access.

    22 min

  2. FEB 10 · VIDEO

    Ep. 54 - HER2-Positive Biliary Tract Cancer: Biomarkers, Targeted Therapy, and Managed Care Access

    In this episode of Unscripted, the AMCP podcast, we talk with Jeffrey Dunn, PharmD, MBA, President and CEO of Cooperative Benefits Group, about the rapidly evolving treatment landscape for HER2-positive biliary tract cancer (BTC) and its implications for managed care. The discussion covers the importance of biomarker testing and molecular profiling in guiding targeted therapy, key NCCN guideline considerations across lines of treatment, and the clinical and economic impact of timely access to HER2-directed therapies. We also discuss payer-provider collaboration strategies to improve testing, coverage alignment, and patient access in this rare and aggressive form of cancer.

    14 min

  3. JAN 30 · VIDEO

    Ep. 53 – 35 Years of AMCP Foundation: Internships & Mentorship in Managed Care

    In this episode, we celebrate the 35th anniversary of the AMCP Foundation. AMCP President Carly Rodriguez, PharmD, FAMCP joins guest host Jordan Bernard, AMCP Foundation/Pfizer Managed Care Intern and Rebecca Brown, AMCP Foundation/Pfizer Managed Care Intern to discuss how the Foundation’s internships and mentorship programs shape the future of managed care. We explore the transition from student to leader, the impact of hands-on research, and Carly’s advice for the next generation of pharmacy innovators.

    22 min

  4. 12/22/2025 · VIDEO

    Ep. 52 - Sickle Cell Disease: Measuring Burden, Managing Pain, and Improving Care

    In this last installment of our rare disease series, we speak with Angela Luong, PharmD, Senior Clinical Consultant at Pharmaceutical Strategies Group. Our discussion focuses on the burden of sickle cell disease, chronic pain management, limited treatment options, and the implications for managed care programs, including the use of data and care coordination to improve patient outcomes. This activity is supported by an independent medical education grant from Agios Pharmaceuticals, Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Sickle Cell Disease Management

    11 min

  5. 12/17/2025 · VIDEO

    Ep. 51 – Hemophilia: Patient Burden, Innovation, and Managed Care Strategy

    In this episode of Unscripted, we continue our rare disease series with a focus on hemophilia and the substantial clinical, financial, and psychosocial burdens it places on patients and families. We speak with Janna Evans, Director of Pharmacy Sales Support at Blue Cross and Blue Shield of Texas, who discusses how health plans manage high-cost therapies, balance individualized patient needs with access requirements, and navigate prior authorization and step-therapy processes. She also highlights the need for better patient-reported outcomes, the day-to-day impact of the disease, and the broader considerations for employers and caregivers within managed care. This activity is supported by an independent medical education grant from Genentech Inc., and Pfizer Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Hemophilia Management.

    11 min

  6. 12/17/2025 · VIDEO

    Ep. 50 - IgA Nephropathy: Exploring Treatment Advances and Managed Care Considerations

    This episode continues AMCP’s rare disease series with an in-depth look at IgA nephropathy (IgAN), a progressive autoimmune kidney disease that often goes undiagnosed until advanced stages. We speak with Ami Gopalan, Senior Vice President of Strategic Content and Growth Optimization at Precision AQ. As a patient living with IgAN, Ami brings both a professional and personal perspective to the discussion as we explore the disease’s silent progression, the burden it places on patients and families, the evolving treatment landscape, and how managed care can better incorporate patient value, clinical guidelines, and emerging evidence to support long-term outcomes. This podcast is supported by an independent medical education grant from Alexion and AstraZeneca Rare Disease. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in IgA Nephropathy Management.

    9 min

  7. 12/05/2025 · VIDEO

    Ep. 49 - Duchenne Muscular Dystrophy: What Truly Matters to Patients and Caregivers

    In this episode of Unscripted, we speak with Steve Kheloussi, PharmD, MBA, FAMCP, Principal Consultant at Kheloussi Consulting, LLC, in the first installment of our four-part series on rare diseases. We discuss a practical overview of Duchenne muscular dystrophy (DMD), the current treatment landscape, and the evidence gaps that complicate payer decision-making. We also touch on the importance of what patients and caregivers need to maintain function, reduce fatigue, and navigate the significant emotional and practical burdens of care. This podcast is supported by an independent medical education grant from ITF Therapeutics. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit:  The Power of Partnership: Bridging Patients and Payers in Duchenne Muscular Dystrophy Management.

    13 min

  8. 12/05/2025 · VIDEO

    Ep. 48 - Understanding Vitiligo: Psychosocial Impact, Early Diagnosis, and Evolving Treatment Approaches

    In this episode of Unscripted, AMCP explores vitiligo as a complex autoimmune disease with significant psychosocial and clinical implications. Dr. Iltefat Hamzavi, MD, FADD discusses the burden of delayed diagnosis, the societal and emotional challenges patients face, and the importance of early, individualized treatment. He outlines current therapeutic approaches—including topical agents, phototherapy, systemic options, and surgical interventions—and highlights the condition’s associations with other autoimmune diseases. The conversation underscores how education, support, and emerging medical advances are reshaping outcomes and quality of life for people living with vitiligo.

    11 min
See All (25)

About

Welcome to Unscripted, the AMCP Podcast — a look inside managed care pharmacy. Listen in as experts explore the challenges, innovations, and opportunities shaping health care for millions of patients.

Information

  • Creator
    AMCP
  • Years Active
    2025 - 2026
  • Episodes
    25
  • Rating
    Clean
  • Copyright
    © Copyright AMCP 2025, All rights reserved.
  • Show Website
    Unscripted - The AMCP Podcast